Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
暂无分享,去创建一个
A. Whittemore | L. Kiemeney | M. Pike | M. Beckmann | P. Fasching | R. Vierkant | T. Sellers | G. Coetzee | P. Hall | F. Couch | J. Chang-Claude | H. Noushmehr | S. Chanock | M. García-Closas | B. Fridley | E. Goode | Robert Brown | B. Karlan | N. Le | A. Berchuck | E. Iversen | J. Lancaster | G. Giles | G. Severi | T. Dörk | M. Southey | D. Easton | J. Cheng | P. Pharoah | D. Lambrechts | A. Antoniou | D. Stram | A. Brooks-Wilson | D. Levine | Ya-Yu Tsai | Daniel Vincent | M. Gore | L. Wilkens | P. Hillemanns | X. Shu | Y. Xiang | W. Zheng | A. Ziogas | H. Anton-Culver | R. Glasspool | U. Menon | A. Gentry-Maharaj | K. Aben | J. Gonzalez-Bosquet | D. Eccles | G. Chenevix-Trench | L. Brinton | J. Lissowska | H. Nevanlinna | N. Bogdanova | J. Cunningham | M. Goodman | S. Kjaer | Jie Lin | F. Bacot | D. Tessier | A. Rudolph | S. Nickels | L. Baglietto | A. Ekici | A. Jakubowska | J. Lubiński | N. Antonenkova | K. Matsuo | A. Wu | S. Teo | Q. Cai | J. Tyrer | S. Wang-gohrke | A. Monteiro | S. Gayther | J. Barnholtz-Sloan | D. Cramer | M. Birrer | N. Wentzensen | H. Jim | I. Vergote | R. Sutphen | R. Ness | Hui-Yi Lin | A. Vitonis | S. Olson | H. Risch | G. Bloom | L. Kelemen | S. Narod | Howard C. Shen | K. Odunsi | I. Campbell | I. Runnebaum | I. Orlow | R. Weber | J. Doherty | J. Schildkraut | S. Kaye | K. Moysich | F. Modugno | M. Cicek | F. Kikkawa | K. Lu | J. McLaughlin | H. Salvesen | L. Massuger | Y. Woo | A. V. van Altena | G. Konecny | E. Bandera | M. K. Halle | C. Pearce | J. Flanagan | F. Heitz | P. Harter | A. du Bois | R. Butzow | K. Lawrenson | Hannah P. Yang | V. McGuire | W. Sieh | L. Rodriguez-Rodriguez | M. Rossing | B. Winterhoff | Zhihua Chen | Honglin Song | C. Phelan | A. Jensen | L. Cook | V. Shridhar | J. Gronwald | S. Tworoger | G. Lurie | R. Edwards | E. Høgdall | C. Høgdall | S. Ramus | E. Wik | C. Krakstad | Xiaotao Qu | J. Permuth-Wey | J. Paul | T. Pejović | I. Rzepecka | A. Dansonka-Mieszkowska | J. Kupryjańczyk | B. Górski | E. Despierre | L. Pelttari | S. Armasu | P. Thompson | M. Dürst | S. Hosono | S. Lambrechts | A. Leminen | Dong Liang | B. Lim | E. Poole | I. Schwaab | Y. Shvetsov | B. Śpiewankiewicz | K. Terry | K. Kalli | M. Larson | S. Renner | T. Nakanishi | Rod Karevan | M. Hoatlin | Janet M. Lee | L. Nedergaard | P. Raska | D. Fenstermacher | Y. A. Chen | Aneliya Velkova | N. Lee | Famida Zulkifli | Ya‐Yu Tsai | T. Pejovic
[1] Brooke L. Fridley,et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer , 2013, Nature Genetics.
[2] W. Chung,et al. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk , 2013, PLoS genetics.
[3] Michelle K. Lupton,et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. , 2012, Human molecular genetics.
[4] N. Eriksson,et al. Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases , 2012, PLoS genetics.
[5] Nicholas R. Lemoine,et al. SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update) , 2012, Nucleic Acids Res..
[6] W. Chung,et al. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[7] J. Marchini,et al. Genotype Imputation with Thousands of Genomes , 2011, G3: Genes | Genomes | Genetics.
[8] R. Vierkant,et al. MicroRNA Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association Consortium , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[9] C. Carlson,et al. Principles for the post-GWAS functional characterization of cancer risk loci , 2011, Nature Genetics.
[10] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[11] R. Vierkant,et al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. , 2011, Cancer research.
[12] Timothy J. Durham,et al. "Systematic" , 1966, Comput. J..
[13] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[14] R. Vierkant,et al. LIN 28 B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer , 2011 .
[15] Dong Liang,et al. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. , 2010, Cancer research.
[16] T. Noda,et al. Rubicon and PLEKHM1 Negatively Regulate the Endocytic/Autophagic Pathway via a Novel Rab7-binding Domain , 2010, Molecular biology of the cell.
[17] A. Whittemore,et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 , 2010, Nature Genetics.
[18] A. Whittemore,et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer , 2010, Nature Genetics.
[19] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[20] C. Harris,et al. Genetic variation in microRNA networks: the implications for cancer research , 2010, Nature Reviews Cancer.
[21] I. Jacobs,et al. Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer. , 2010, Neoplasia.
[22] P. Morin,et al. MicroRNAs in ovarian carcinomas. , 2010, Endocrine-related cancer.
[23] Eden R Martin,et al. Genome‐Wide Association Study Confirms SNPs in SNCA and the MAPT Region as Common Risk Factors for Parkinson Disease , 2010, Annals of human genetics.
[24] B. Karlan,et al. Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. , 2010, Gynecologic oncology.
[25] W. Wong,et al. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. , 2009, Cancer cell.
[26] A. Whittemore,et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 , 2009, Nature Genetics.
[27] Brian D Athey,et al. New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites. , 2009, Genome research.
[28] Jack A. Taylor,et al. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies , 2009, Nucleic Acids Res..
[29] J. Chang-Claude,et al. Role of genetic polymorphisms and ovarian cancer susceptibility , 2009, Molecular oncology.
[30] Nathaniel D. Heintzman,et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression , 2009, Nature.
[31] Muin J. Khoury,et al. Gene Prospector: An evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases , 2008, BMC Bioinformatics.
[32] Praveen Sethupathy,et al. MicroRNA target site polymorphisms and human disease. , 2008, Trends in genetics : TIG.
[33] R. Tothill,et al. Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome , 2008, Clinical Cancer Research.
[34] John L Hopper,et al. Multiple loci with different cancer specificities within the 8q24 gene desert. , 2008, Journal of the National Cancer Institute.
[35] H. Shill,et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease , 2008, Neurology.
[36] Tian-Li Wang,et al. MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer , 2008, PloS one.
[37] Jae Hoon Kim,et al. MicroRNA Expression Profiles in Serous Ovarian Carcinoma , 2008, Clinical Cancer Research.
[38] Anil K Sood,et al. Early events in the pathogenesis of epithelial ovarian cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] E. Halperin,et al. Estimating Local Ancestry in Admixed Populations , 2022 .
[40] Huan Yang,et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. , 2008, Cancer research.
[41] A. Dimmler,et al. The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer. , 2008, Cancer research.
[42] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[43] J. Steitz,et al. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR , 2007, Proceedings of the National Academy of Sciences.
[44] Héctor Peinado,et al. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? , 2007, Nature Reviews Cancer.
[45] C. Croce,et al. MicroRNA signatures in human ovarian cancer. , 2007, Cancer research.
[46] R. Pfundt,et al. A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism , 2006, Nature Genetics.
[47] G. Binetti,et al. The H2 MAPT haplotype is associated with familial frontotemporal dementia , 2006, Neurobiology of Disease.
[48] J. Boyd,et al. Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer , 2005, Clinical Cancer Research.
[49] K. Gunsalus,et al. Combinatorial microRNA target predictions , 2005, Nature Genetics.
[50] H. Stefánsson,et al. A common inversion under selection in Europeans , 2005, Nature Genetics.
[51] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[52] M. Katoh,et al. Identification and characterization of ARHGAP27 gene in silico. , 2004, International journal of molecular medicine.
[53] T. Tamaya,et al. Clinical Implications of Expression of ETS-1 Related to Angiogenesis in Metastatic Lesions of Ovarian Cancers , 2004, Oncology.
[54] M. Mattei,et al. Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1 , 1992, Molecular and cellular biology.